Loading institutional data...
Loading institutional data...
Strong institutional distribution: ownership decreased -95.77% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 1 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How a revenue dollar becomes profit — FY2024
Each value shows its share of revenue below it (common-size).
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $277.2M 100.0% | $232.3M 100.0% | $722.7M 100.0% | $439.4M 100.0% | $46.6M 100.0% | $35.2M 100.0% | $8.2M 100.0% | $327K 100.0% | $11.0M 100.0% | $4.0M 100.0% |
| Research & Development | $61.5M 22.2% | $54.9M 23.6% | $46.6M 6.4% | $32.2M 7.3% | $28.6M 61.5% | $62.3M 177.0% | $75.0M 914.3% | $65.0M 19874.0% | $84.5M 765.1% | $86.9M 2146.7% |
| Selling, General & Admin | $170.4M 61.5% | $152.9M 65.8% | $131.4M 18.2% | $100.2M 22.8% | $79.3M 170.3% | $75.0M 212.9% | $64.8M 790.1% | $27.4M 8369.1% | $37.3M 337.4% | $22.2M 547.7% |
| Total Operating Expenses | $281.4M 101.5% | $269.3M 115.9% | $439.2M 60.8% | $305.0M 69.4% | $114.9M 246.9% | $170.1M 482.9% | $161.5M 1970.2% | $96.3M 29459.3% | $121.8M 1102.5% | $109.1M 2694.4% |
| Operating Income | -$4.1M -1.5% | -$37.0M -15.9% | $283.5M 39.2% | $134.5M 30.6% | -$68.4M -146.9% | -$134.8M -382.9% | -$153.3M -1870.2% | -$96.0M -29359.3% | -$110.7M -1002.5% | -$105.1M -2594.4% |
| Interest Expense | $6.8M 2.5% | $6.8M 2.9% | $6.7M 0.9% | $11.2M 2.5% | $19.1M 40.9% | $17.0M 48.2% | $9.3M 113.9% | — | — | $572K 14.1% |
| Interest & Investment Income | $36.5M 13.2% | $32.0M 13.8% | $7.9M 1.1% | $140K 0.0% | $1.3M 2.7% | $3.4M 9.6% | $3.8M 46.7% | $1.3M 408.9% | $755K 6.8% | $205K 5.1% |
| Other Income (Expense), net | $293K 0.1% | -$152K -0.1% | $111K 0.0% | $922K 0.2% | -$897K -1.9% | $731K 2.1% | -$70K -0.9% | -$486K -148.6% | -$2.5M -22.6% | $317K 7.8% |
| Pretax Income | $30.9M 11.1% | -$4.4M -1.9% | $294.3M 40.7% | $77.5M 17.6% | -$75.2M -161.6% | -$152.6M -433.3% | -$158.9M -1938.3% | -$95.2M -29099.1% | -$112.4M -1018.2% | -$106.8M -2636.9% |
| Income Tax Expense | $3.5M 1.3% | $2.0M 0.9% | $1.1M 0.2% | $808K 0.2% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% |
| Net Income | $27.3M 9.9% | -$6.4M -2.8% | $293.2M 40.6% | $76.7M 17.5% | -$75.2M -161.6% | -$152.6M -433.3% | -$158.9M -1938.3% | -$95.2M -29099.1% | -$112.4M -1018.2% | -$106.8M -2636.9% |
| Per Share | ||||||||||
| EPS (Basic) | $0.21 | $-0.05 | $2.32 | $0.62 | $-0.75 | $-2.16 | $-2.55 | — | — | — |
| EPS (Diluted) | $0.20 | $-0.05 | $1.97 | $0.57 | $-0.78 | $-2.16 | $-2.55 | — | — | — |
| Weighted Avg Shares (Basic) | 130.0M | 128.7M | 126.4M | 116.3M | 100.8M | 72.0M | 62.4M | — | — | — |
| Weighted Avg Shares (Diluted) | 133.3M | 128.7M | 150.8M | 133.0M | 101.5M | 72.0M | 62.4M | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $100M buybacks = $100M returned on $60M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 5%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Ranked against 1111 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | $1.05T | 51.0× | — | 16.1× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $679.0B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $620.1B | 23.4× | — | 6.6× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $435.4B | 104.3× | 31.4× | 7.1× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| UNH | $374.0B | 31.2× | 21.4× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| BDRX | $359.1B | — | — | — | — | — | — | — | — | — | 7 |
| MRK | $321.1B | 17.6× | — | 4.9× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| NVSEF | $289.9B | — | — | — | — | — | — | — | — | — | 2 |
| AZN | $250.4B | — | — | — | — | — | — | — | — | — | 1,248 |
| AMGN | $219.7B | 28.7× | 18.3× | 6.0× | 10.0% | 67.2% | 21.0% | 89.1% | 13.1% | 3.5× | 3,014 |
| TMO | $217.8B | 32.6× | 28.5× | 4.9× | 3.9% | — | 15.1% | 12.6% | 7.0% | 4.9× | 2,481 |
| ABT | $183.9B | 28.4× | 19.5× | 4.2× | 5.7% | 56.4% | 14.7% | 12.5% | 10.5% | 1.0× | 2,964 |
| GILD | $163.5B | 19.4× | 18.1× | 5.5× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| PFE | $146.7B | 19.0× | — | 2.3× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $141.1B | 39.5× | 29.3× | 5.7× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $133.2B | 47.7× | 36.6× | 13.2× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| SYK | $128.8B | 40.1× | 21.8× | 5.1× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| CVS | $126.0B | 71.3× | 12.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| VRTX | $123.1B | 31.6× | 26.9× | 10.3× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| MDT | $110.1B | 23.1× | 11.7× | 3.0× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| GLAXF | $106.9B | — | — | — | — | — | — | — | — | — | 5 |
| MCK | $102.7B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| SNYNF | $101.3B | — | — | — | — | — | — | — | — | — | 5 |
| HCA | $92.0B | 14.5× | — | 1.2× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $86.4B | 15.5× | 14.8× | 0.4× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| DVAX | — | — | — | — | 19.4% | — | 9.9% | 4.6% | 4.6% | — | 1 |
Peers = companies sharing DVAX's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
No material risks flagged.
Where each multiple sits in its own 13-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 13-yr history.
Is the profit real, and how strong is the balance sheet?
FY2024 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|
| R&D | 19874.0 | 914.3 | 177.0 | 61.5 | 7.3 | 6.4 | 23.6 | 22.2 |
| SG&A | 8369.1 | 790.1 | 212.9 | 170.3 | 22.8 | 18.2 | 65.8 | 61.5 |
| Operating Income | -29359.3 | -1870.2 | -382.9 | -146.9 | 30.6 | 39.2 | -15.9 | -1.5 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.9 | 1.3 |
| Net Income | -29099.1 | -1938.3 | -433.3 | -161.6 | 17.5 | 40.6 | -2.8 | 9.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on DVAX: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.